Synergistic Tissue Ablation and Assessment System with Integrated AI, IoT, and Advanced Materials
Legal Citation
Summary of the Inventive Concept
A novel system integrating artificial intelligence, Internet of Things (IoT), blockchain, and advanced nanomaterials to enhance tissue ablation and assessment, providing real-time lesion progression prediction, secure patient data management, and optimized ablation protocols.
Background and Problem Solved
The original patent disclosed a tissue ablation and assessment system with limitations in real-time monitoring, data security, and optimized ablation protocols. The new inventive concept addresses these limitations by synergistically combining distinct technologies to create a more powerful and efficient system.
Detailed Description of the Inventive Concept
The system consists of an AI module for real-time lesion progression prediction, an IoT-enabled data acquisition device for remote monitoring and analysis of ablation signals, a blockchain-secured data storage and transmission system for secure patient data management, and a novel nanomaterial-based antenna electrode for enhanced electromagnetic radiation transmission and reception. The system integrates these components to provide optimized ablation protocols, real-time tissue parameter monitoring, and secure patient data management.
Novelty and Inventive Step
The new claims introduce the synergistic combination of AI, IoT, blockchain, and advanced nanomaterials, which is non-obvious and novel compared to the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful and efficient system for tissue ablation and assessment.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different AI algorithms, IoT protocols, or blockchain architectures. Variations may include the integration of additional technologies, such as machine learning-based predictive analytics or IoT-enabled catheter tracking systems.
Potential Commercial Applications and Market
The synergistic tissue ablation and assessment system has potential commercial applications in the medical device industry, particularly in the fields of cardiology, oncology, and neurology. The target market includes hospitals, clinics, and research institutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1815 |
| A | A61 | A61B5/0093 |
| A | A61 | A61B5/05 |
| A | A61 | A61B5/0507 |
| A | A61 | A61B5/0538 |
| A | A61 | A61B18/1492 |
| A | A61 | A61B2017/00026 |
| A | A61 | A61B2017/00039 |
| A | A61 | A61B2017/00084 |
| A | A61 | A61B2017/00106 |
| A | A61 | A61B2018/00023 |
| A | A61 | A61B2018/00029 |
| A | A61 | A61B2018/00351 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00636 |
| A | A61 | A61B2018/00702 |
| A | A61 | A61B2018/00773 |
| A | A61 | A61B2018/00785 |
| A | A61 | A61B2018/00791 |
| A | A61 | A61B2018/00827 |
| A | A61 | A61B2018/00875 |
| A | A61 | A61B2018/1435 |
| A | A61 | A61B2018/183 |
| A | A61 | A61B2018/1823 |
| A | A61 | A61B2018/1838 |
| A | A61 | A61B2018/1846 |
| A | A61 | A61B2018/1853 |
| A | A61 | A61B2018/1861 |
| A | A61 | A61B2018/1892 |
| A | A61 | A61B2090/065 |
| A | A61 | A61B2218/002 |
| A | A61 | A61B2576/023 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for tissue ablation, electromagnetic signal processing, and diagnostic imaging systems, requiring advanced knowledge of electrical engineering, medical instrumentation, signal processing, and biomedical technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in electrical engineering or biomedical engineering, possessing expertise in RF/microwave signal transmission, tissue interaction technologies, and medical diagnostic instrumentation
Obviousness Rationale
A PHOSITA would recognize that integrating AI, IoT, and advanced materials into the existing tissue ablation system represents a predictable technological evolution using known techniques for enhancing medical diagnostic technologies. The core signal transmission and tissue assessment principles remain fundamentally consistent with the source patent, with the PTD introducing incremental technological improvements using standard engineering design approaches. The combination of existing technologies to achieve enhanced monitoring and diagnostic capabilities would be considered an obvious extension of the original patent's core technological framework.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,253 |
|---|---|
| Title | Tissue ablation and assessment system and method of use thereof |
| Assignee(s) | The Johns Hopkins University |